Lam Research (NASDAQ:LRCX) Updates Q2 Earnings Guidance

Lam Research (NASDAQ:LRCX) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of $0.77-0.97 for the period, compared to the consensus earnings per share estimate of $0.84. The company issued revenue guidance of $4.0-4.6 billion, compared to the consensus revenue estimate of $4.24 billion. Lam Research also updated its Q2 2025 guidance to 0.770-0.970 EPS.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. B. Riley cut their price objective on shares of Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a report on Wednesday. Wells Fargo & Company cut their price objective on shares of Lam Research from $88.00 to $85.00 and set an “equal weight” rating for the company in a report on Thursday. TD Cowen increased their price objective on shares of Lam Research from $100.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Morgan Stanley cut their price objective on shares of Lam Research from $81.00 to $77.00 and set an “equal weight” rating for the company in a report on Wednesday. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $100.00 price objective on shares of Lam Research in a report on Thursday. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $97.03.

Lam Research Stock Up 1.4 %

Shares of LRCX opened at $77.68 on Friday. The company has a market cap of $100.68 billion, a PE ratio of 26.79, a P/E/G ratio of 1.89 and a beta of 1.47. The business has a fifty day moving average of $79.44 and a 200 day moving average of $89.84. Lam Research has a 52-week low of $57.44 and a 52-week high of $113.00. The company has a quick ratio of 2.00, a current ratio of 2.97 and a debt-to-equity ratio of 0.52.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.05. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $4.06 billion. Lam Research had a return on equity of 48.71% and a net margin of 25.68%. Lam Research’s revenue was up 19.7% on a year-over-year basis. During the same period last year, the company earned $6.85 earnings per share. On average, sell-side analysts expect that Lam Research will post 3.23 EPS for the current year.

Lam Research Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Tuesday, September 17th were given a dividend of $0.23 per share. The ex-dividend date was Tuesday, September 17th. This represents a $0.92 annualized dividend and a dividend yield of 1.18%. Lam Research’s dividend payout ratio (DPR) is 31.72%.

Insider Transactions at Lam Research

In other news, CAO Christina Correia sold 647 shares of Lam Research stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the sale, the chief accounting officer now directly owns 4,267 shares in the company, valued at approximately $3,488,315.17. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.29% of the company’s stock.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.